Biotechnology News

August 7, 2012

BOSTON--(BUSINESS WIRE)--The Harvard Clinical Research Institute announced today the successful completion of randomization into the DAPT Study, with the total number of patients randomized exceeding the upper goal set.

August 7, 2012

LOS ANGELES--(BUSINESS WIRE)--FIDELIS DIAGNOSTICS PARTNERS WITH EXALENZ BIOSCIENCE TO ADD H. PYLORI BREATH TESTING SOLUTIONS TO ITS PORTFOLIO OF SERVICES

August 7, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for operating room basins

August 7, 2012

WASHINGTON--(BUSINESS WIRE)--Kelley Bernheim Dolinsky, LLC, a national consumer safety law firm specializing in dangerous pharmaceutical litigation -- www....

August 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Today, an equal 29% of companies align their HEOR teams under market access, while the remaining surveyed companies house HEOR under clinical research and development, marketing or other departments...

August 7, 2012

TORONTO--(BUSINESS WIRE)--Functional Neuromodulation begins study of deep brain stimulation for Alzheimer's Disease.

August 7, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus (NASDAQ: CERS) announced today its distributor for Turkey has signed an agreement with the Florence Nightingale Hospital of Turkey, to supply the INTERCEPT Blood System for platelets & plasma.

August 7, 2012

SAN DIEGO--(BUSINESS WIRE)--SNMX 2Q12 Results: Development activities for new S52617 High Fructose Corn Syrup (HFCS) & sucrose modifier; international regulatory approvals. Call today 11am EST; audio at IR tab,...

August 7, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will present an update on its primary drug candidate, neratinib, at the Wedbush PacGrow Life Sciences Conference on August 14.

August 7, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, announced that favorable results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate aldoxorubicin...

August 7, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the successful pricing of two series of senior unsecured notes for an aggregate principal amount of $1.5 billion. Of these notes, $500 million will mature in 2017...

August 7, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today reported financial results for the second quarter ended June 30, 2012. For the second quarter of 2012, total operating expenses were $44.1 million, compared to $39.2...

August 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its recent clinical and business progress and reported its financial results for the second quarter of 2012. “Our business has evolved...

August 7, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds as expected, among recently treated dyslipidemia patients, share of Pfizer’s...

August 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced the publication of its 2011 Corporate Social Responsibility (CSR) Report....

August 7, 2012

SEATTLE, Wash.--(BUSINESS WIRE)--NanoString Technologies, Inc. announced the appointment of Dale R. Levitzke as Vice President of Global Sales, Life Sciences

August 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) today reported financial results for the second quarter ended June 30, 2012. “During the first half of 2012 we made tremendous progress advancing our internal pipeline candidates...

August 7, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the second quarter ending June 30, 2012. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen, stated, "Among our notable achievements during...

August 7, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead to Report Fiscal 2012 Third Quarter Financial Results on Monday, August 13, 2012

August 7, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Announces Complete Line of Bladeless Access Ports and Closure Products for Laparoscopic Procedures

August 7, 2012

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode's newly awarded patent solidifies its intellectual property portfolio by further protecting the Barcoded Magnetic Beads technology and providing its products long term market value.

August 7, 2012

ZWINGENBERG, Germany--(BUSINESS WIRE)--Evonik Industries und BRAIN kooperieren

August 7, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide announced today the 20th year anniversary of its founding.

August 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC), an innovation leader in providing authentication solutions, and developer of Tactivo, a smart casing that provides both smart card and fingerprint authentication to...

August 6, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) Announces 2Q 2012 Financial Results: Business Update / Quarterly Conference Call Set for August 7, 2012,
at 8:00 AM EDT

August 6, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the fourth quarter and full year of fiscal 2012 on Monday, August 13, 2012, and will hold a conference call on Tuesday, August 14, 2012 at 9:00...

August 6, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) announced today that Johnson & Johnson has issued a press release regarding the discontinuation of Phase 3 development of bapineuzumab IV in mild to moderate Alzheimer’s. The press...

August 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announces it is hosting a conference call and Webcast on Tuesday, August 14, 2012 at 4:30 p.m. ET to discuss the Company’s second quarter results.

August 6, 2012

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will host an investor meeting on Thursday, September 13, 2012, to update the investment community on the Company and its growth initiatives,...

August 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter 2012, and company highlights. “This was an exceptional...

August 6, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation, a medical device company, announced today that it has received approval from the Mexican Ministry of Health’s Comisiόn Federal para la Protecciόn contra Riesgos Sanitarios, COFEPRIS, for...

August 6, 2012

OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec, Inc. (OTC: UNVC) a specialty pharmaceutical company, announced that its Board of Directors have approved a stock repurchase program. Under the program management is authorized to repurchase up to 100,...

August 6, 2012

MADISON, N.J.--(BUSINESS WIRE)--This August, up to 51 percent of Americans will take a summer vacation, but many women will take steps to shield themselves from the sun’s harmful ultraviolet (UV) rays. Direct exposure to sunlight is the primary...

August 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

August 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of psoriasis, Abbott/Eisai’s Humira has displaced Amgen/Stiefel...

August 6, 2012

WASHINGTON--(BUSINESS WIRE)--Researchers combined bouncing photons with advanced optics to enable them to “see” what’s hidden around the corner. Their work was published in OSA’s open-access journal Optics Express.

August 6, 2012

JACKSONVILLE, Fla.--(BUSINESS WIRE)--HemaTerra Technologies, provider of end-to-end operational software products to blood centers, announced that it will work with Fenwal Inc. to develop a companion product to HemaConnect, the industry’s leading...

August 6, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharma bucks outsourcing trend to add hundreds of U.S. manufacturing jobs with major expansion. Generic maker’s $120 million investment to boost capacity and employment at multiple U.S. sites.

August 6, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--GlobalNet Services, Inc., (GNSI) has received an award as a prime contractor on the Chief Information Officer Special Programs 3 (CIO-SP3) Small Business vehicle. CIO-SP3 Small Business is a government-wide...

August 6, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its intention to offer, subject to market and other conditions, senior unsecured notes under a shelf registration statement on Form S-3 on file with the Securities...

August 6, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. announced today that SWOG has selected Sequenta’s LymphoSIGHT platform for the measurement of Minimal Residual Disease (MRD) in a clinical trial.

August 6, 2012

PLANTATION, Fla.--(BUSINESS WIRE)--Accu-Break Pharmaceuticals, inventor of patented scored tablet designs and systems, enters into a product development and license agreement with Alembic Pharmaceuticals Limited

August 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that it plans to offer, subject to market and other conditions, 20,000,000 shares of its common stock and $225 million aggregate principal amount of...

August 6, 2012

NEW YORK--(BUSINESS WIRE)--The major trade group for the global pharmaceutical industry, Pharmaceutical Research and Manufacturers of America, and economic consulting firm Analysis Group, Inc.

August 6, 2012

TRENTON, N.J.--(BUSINESS WIRE)--New Jersey biotechnology industry showing increases in number of companies and employees from 2010 to 2012, according to latest survey.

August 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) announced that the Company will be presenting at Wedbush PacGrow Lifesciences Conference and the Canaccord Genuity Growth Conference.

August 6, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada, Ltd. (TASE: KMDA), a biopharmaceutical company engaged in development, manufacturing and marketing of specialty life-saving therapeutics announced today it has entered into an exclusive distribution...

August 6, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Announces New Strategic Partnership with Central Business USA for South America

August 6, 2012

NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (NASDAQ: ARCC) announced today that it closed its first venture finance transaction with Respicardia®, Inc., an early stage company developing a medical device targeted to improve respiratory...